Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

Historical Holders from Q2 2016 to Q3 2025

Symbol: MRUS on Nasdaq
Type / Class: Equity / Common Shares, Euro 0.09 nominal value per share
Shares outstanding: 75,893,250
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 69,045,071
Holdings value: $6,500,256,699
% of all portfolios: 0.03%
Number of holders: 260
Number of buys: 168
Number of sells: -112
Average buys %: +0.01%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Paradigm Biocapital Advisors LP	6.2%	+22%	$440,035,446	+$105,420,791	4,673,770	+32%	Paradigm BioCapital Advisors LP	30 Sep 2025
Commodore Capital LP	4.7%	-13%	$192,112,500	-$12,262,500	3,525,000	-6%	Commodore Capital LP	30 Jun 2025
FMR LLC	3.7%		$262,013,365		2,782,935		FMR LLC	30 Sep 2025
RTW INVESTMENTS, LP	2.7%		$190,679,830		2,025,277		RTW Investments, LP	30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP	0.6%	-88%	$43,223,041	-$307,647,929	459,087	-88%	Wellington Management Group LLP	30 Sep 2025

Institutional Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	69,045,071	$6,500,256,699	-$237,056,971	$70,697,235	$155,545,215	$94.15	260
2025 Q2	74,805,584	$3,934,869,962	+$216,360,414	$29,224,560	$16,348,120	$52.6	200
2025 Q1	70,836,661	$2,982,592,220	+$29,910,241	$4,061,685	$14,938,067	$42.09	185
2024 Q4	70,372,416	$2,959,108,162	-$77,769,391	$3,603,685	$4,662,935	$42.05	190
2024 Q3	69,023,165	$3,453,000,438	+$64,077,831	$14,963,272	$12,135,284	$49.96	186
2024 Q2	66,505,364	$3,935,120,138	+$944,081,758	$13,153,491	$16,259,645	$59.17	176
2024 Q1	51,233,583	$2,306,963,444	+$30,953,081	$8,456,634	$4,651,599	$45.03	155
2023 Q4	51,213,294	$1,408,520,114	+$91,147,769	$2,948,000	$893,750	$27.5	128
2023 Q3	47,491,302	$1,119,891,239	+$142,312,228	$2,820,168	$1,207,296	$23.58	112
2023 Q2	41,257,480	$1,086,320,462	+$132,534,899	$1,829,935	$1,192,749	$26.33	111
2023 Q1	36,522,352	$671,981,883	+$2,460,096	$322,000	$2,577,920	$18.4	103
2022 Q4	36,513,596	$564,873,025	-$17,806,534	$51,051	$611,065	$15.47	91
2022 Q3	34,387,134	$688,765,575	-$18,872,808	$318,000		$20.03	100
2022 Q2	35,043,797	$793,382,953	+$41,956,175			$22.64	93
2022 Q1	33,209,323	$878,080,617	-$17,319,721		$0	$26.44	94
2021 Q4	32,999,686	$1,049,315,646	+$312,713,905		$1,863,000	$31.8	103
2021 Q3	22,166,080	$487,779,159	-$93,778,101			$22	63
2021 Q2	26,784,956	$564,348,331	+$1,605,878			$21.07	66
2021 Q1	26,725,442	$558,325,760	+$113,660,788			$20.89	58
2020 Q4	22,046,847	$386,593,075	+$58,495,806			$17.53	43
2020 Q3	18,197,336	$218,401,600	-$6,778,757			$12	41
2020 Q2	18,590,455	$299,121,000	+$19,430,635			$16.09	42
2020 Q1	18,005,073	$217,858,000	+$1,723,160			$12.1	29
2019 Q4	17,842,709	$251,227,000	+$61,139,029			$14.08	37
2019 Q3	11,877,122	$211,649,000	+$2,519,436			$17.82	26
2019 Q2	11,830,344	$173,308,000	-$426,523			$14.65	26
2019 Q1	11,859,344	$175,160,000	-$2,838,143			$14.77	24
2018 Q4	12,071,835	$169,003,000	-$3,568,060			$14	26
2018 Q3	12,054,339	$237,947,000	-$3,669,154			$19.74	29
2018 Q2	12,310,935	$280,168,000	+$31,199,716			$22.76	25
2018 Q1	9,796,183	$181,524,000	+$38,987,498			$18.53	20
2017 Q4	5,703,167	$110,530,000	-$2,557,404			$19.4	16
2017 Q3	5,831,528	$115,872,000	-$9,235,916			$19.87	16
2017 Q2	6,307,149	$99,970,000	-$1,169,691			$15.85	16
2017 Q1	6,339,526	$154,589,000	+$35,982,508			$24.38	22
2016 Q4	4,863,545	$102,671,000	+$3,571,943			$21.11	11
2016 Q3	4,695,313	$78,616,000	+$190,127			$16.75	12
2016 Q2	4,811,781	$38,568,000	+$38,568,000			$7.99	16